[1] |
CHEN Linmu, HUANG Yunxiu.
Chitosan oligosaccharides alleviates the formation of atherosclerotic plaque through up-regulating core-fucosylation of SRBI in mice
[J]. Basic & Clinical Medicine, 2024, 44(4): 474-482.
|
[2] |
YU Hanqiao, LI Chao, YU Yubin, FENG Lina, SHENG Xiaosheng, YE Xiaoxia, WANG Linyan.
Inhibition of triggering receptor expressed on myeloid cells-1(TREM-1) attenuates chronic intermittent hypoxia-induced atherosclerosis in mouse models
[J]. Basic & Clinical Medicine, 2024, 44(3): 368-373.
|
[3] |
ZHANG Xiuli, HU Xiaogang, MO Jun, CHEN Ling.
Guanxinning tablet alleviates carotid atherosclerotic plaque injury in rats
[J]. Basic & Clinical Medicine, 2024, 44(2): 192-198.
|
[4] |
GUO Jianhong, WANG Yaling, CUI Wenguang.
Research progress on the role of lipoprotein- associated phospholipase A2 in acute coronary syndrome
[J]. Basic & Clinical Medicine, 2024, 44(1): 103-107.
|
[5] |
SONG Xingming, Harisa·ERKENJIAN, Dilihumal·ABLAITI, GAO Ying.
Research progress of endothelial lipase as a therapeutic target for coronary heart disease
[J]. Basic & Clinical Medicine, 2023, 43(9): 1443-1447.
|
[6] |
DU Fenghe, LIU Bao.
Research progress on the mechanism of perivascular adipose tissue inflammation promoting atherosclerosis
[J]. Basic & Clinical Medicine, 2023, 43(4): 685-689.
|
[7] |
WANG Fei, LI Wenxuan, DING Junqiong, LIU Zhen, WANG Xiaoming, YANG Ju, WANG Dalian.
Nitric oxide synthase inhibitor reduces airway inflammation in mouse models with asthma
[J]. Basic & Clinical Medicine, 2023, 43(3): 462-467.
|
[8] |
LIU Yifei, WANG Xinyu, WANG Jiahui, DU Xiaobing, WANG Tu, ZHAO Juan.
Urotensin Ⅱ receptor antagonist(urantide) alleviates renal injury in rats with atherosclerosis
[J]. Basic & Clinical Medicine, 2023, 43(11): 1668-1672.
|
[9] |
LIU Zhen-zhu, LI Jing, HE Dan, QU Peng.
Research progress of PI3K signaling pathway regulating the pathogenesis of atherosclerosis
[J]. Basic & Clinical Medicine, 2022, 42(9): 1428-1432.
|
[10] |
ZHAO Mao-yu, LI You-mei, LIU Huan-yun, MAO Qi.
Research progress of insulin resistance markers in atherogenesis
[J]. Basic & Clinical Medicine, 2022, 42(8): 1302-1305.
|
[11] |
XIE Si-an, XU Jun-xuan, NING Ting-ting, ZHANG Nan, ZHU Sheng-tao, LIU Si.
VAV1 is a potential target and a new biomarker for the prognosis of atherosclerosis
[J]. Basic & Clinical Medicine, 2022, 42(7): 1092-1098.
|
[12] |
ZHANG Qi-yue, ZHANG Wei-li.
The role of vascular aging in atherosclerosis
[J]. Basic & Clinical Medicine, 2022, 42(3): 372-377.
|
[13] |
ZHAO Chuan-rong, ZHOU Jing.
Shear-sensitive factors in therapeutic targets for atherosclerosis
[J]. Basic & Clinical Medicine, 2022, 42(3): 378-383.
|
[14] |
LI Huan-huan, ZHANG Yu-qi, LYU Hai-hong.
Research progress of oxidative stress increasing the risk of cardiovascular disease of polycystic ovary syndrome patients
[J]. Basic & Clinical Medicine, 2022, 42(12): 1950-1954.
|
[15] |
SHENG Yan, LI Xiu-mao, GUO Xin, XIE Qian, HUANG Ren-jie, SHENG Xin.
Reduction of carotid perfusion promotes inflammation of vascular endothelial cells in rabbits
[J]. Basic & Clinical Medicine, 2021, 41(9): 1247-1252.
|